Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice

Tubercle and Lung Disease

Volumn 78, Issue 5-6, 1997, Pages 257-261

  Johnson, C M ^a   Cooper, A M ^a   Frank, A A ^a   Bonorino, C B C ^b   Wysoki, L J ^b   Orme, I M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ISONIAZID;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE DISRUPTION; LUNG TUBERCULOSIS; MEMORY CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031396598     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(97)90006-X     Document Type: Article

References (30)

1. Zinsser H, Enders J F, Fothergill C D. Immunity in syphilis and tuberculosis immunity. In: Principles and Applications of Medicine and Public Health. New York: Macmillan 1939.
2. Forget A, Benoit J C, Turcotte R, Gusew-Chartrand N. Enhancement activity of antimycobacterial sera in experimental M. bovis (BCG) infection in mice. Infect Immun 1976; 13: 1301-1306.
3. Lefford M J, McGregor D D, Mackaness G B. Immune reponse to Mycobacterium tuberculosis in rats. Infect Immun 1973; 8: 182-189.
4. Mackaness G B. The immunology of antituberculosis immunity. American Review of Respiratory Disease 1968; 97: 337-344.
5. Raffel S. The mechanism involved in acquired immunity to tuberculosis. In: Wolstenholme G E W, Cameron M P eds. Ciba Foundation Symposium on Experimental Tuberculosis Bacillus and Host. Boston: Little, Brown and Co. 1955: pp 261-282
6. Suter E. Passive transfer of acquired resistance to infection with Mycobacterium tuberculosis by means of cells. American Review of Respiratory Disease 1961; 83: 535-543.
7. Vordermeier H M, Venkataprasad N, Harris D P, Ivanyi J. Increase of tuberculosis infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996; 106: 312-316.
8. Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin ìchain gene. Nature 1991; 350: 423-426.
9. Wynn T A, Eltoum I, Oswald I P, Cheever A W, Sher A. Endogenous interleukin (IL) 12 regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994; 179: 1551-1561.
10. Cooper A M, Roberts A D, Rhoades E R, Callahan J E, Getzy D M, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis. Infect Immum 1995; 84: 423-432.
11. Svetíc A, Finkelman F D, Jian Y C et al. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 1991; 147: 2391-2397.
12. Wynn T A, Eltoum I, Cheever A W, Lewis F A, Gause W C, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993; 151: 1430-1440.
13. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988; 140: 3589-3593.
14. Epstein M M, Di Rosa F, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995; 182: 915-922.
15. Asano M S, Ahmed R. CD8 T cell memory in B cell-deficient mice. J Exp Med 1996; 183: 2165-2174.
16. Di Rosa F, Matzinger P. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med 1996; 183: 2153-2163.
17. Marcotte H, Levesque D, Delanay K et al. Pneumocystis carinii Infection in transgenic B cell-deficient mice. J Infect Dis 1996, 173: 1034-1037.
18. Chandramuki A, Bothamley G H, Brennan P J, Ivanyi J. Levels of antibody to defined antigens of Mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol 1989: 27: 821-825.
19. Huygen K, Ljungqvist L, Berg R, Vooren J V. Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect Immun 1990; 58: 2192-2197.
20. Ivanyi J, Thole J. Specificity and function of T- and B-cell recognition in tuberculosis. In: Bloom B R ed. Tuberculosis: Pathogenesis, Protection, and Control. Washington DC: ASM Press 1994: pp 437-458.
21. Orme IM, Miller E, Roberts A D et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992; 148: 198-196.
22. Bajaj G, Rattan A, Ahmad P. Circulating immune complexes in tuberculosis - an indicator of activity. Indian J Pediatr 1990; 57: 203-207.
23. Daniel T M. Circulating immune complexes in tuberculosis. American Review of Respiratory Disease 1986; 134: 199-200.
24. Johnson N M, McNicol M W, Burton-Kee EJ, Mowbray J F. Circulating immune complexes in tuberculosis. Thorax 1981; 36: 610-617.
25. May J J, Katilus J, Henson P M, Dreisin R B. The purification and identification of circulating immune complexes in tuberculosis. American Review of Respiratory Disease 1983; 128: 920-925.
26. Near K A, Lefford M J. Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis. J Clin Microbiol 1992; 30: 1105-1110.
27. Rhoades E R, Frank A A, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997; 78: 57-66.
28. + cells. Nature 1994; 372: 691-694.
29. Sieling P A, Chatterjee D, Porcelli S A et al. CD1-Restricted T cell recognition of microbial lipoglycan antigens. Science 1995; 269: 227-230.
30. Bendelac A. CD1 : Presenting unusual antigens to unusual T lymphocytes. Science 1995; 269: 185-186.